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IranAbstract Introduction: Identifying factors that delay diagnosis of tuberculosis (TB) are important
for the health system when timely patient treatment and reducing TB transmission are desirable
goals. Aim of this study was to investigate the prognostic factors that delay TB diagnosis.
Material and methods: This retrospective cohort study used National TB Program (NTP) data
from 1056 TB patients during 2006–2014 in Hamadan province, western Iran. The Cox regression
model was performed to determine associations between baseline explanatory variables and survival
outcome with Hazard Ratio HRs (95% CIs).
Results: N (%) of delay in TB diagnosis more than 90 days was significantly higher in male
patients, new case patients and pulmonary positive cases. After adjustment for covariates, HR
(95% CI) in relapsed TB compared to new cases was 0.67 (0.53, 0.85) and these figures for positive
pulmonary cases and extra pulmonary cases in compared to negative pulmonary cases were 0.80
(0.68, 0.94) and 0.84 (0.73, 0.98) respectively.
Conclusion: A high proportion of patients had delays in diagnosis exceeding three months. Our
findings suggest that male gender, new cases, positive and extra pulmonary cases might increase the
risk for delayeddiagnosis among TB patients.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Tuberculosis (TB) is known as a global public health problem
accounting 9.4 million incident cases and 1.4 million deaths in
2012 [1]. Many factors including HIV epidemics, population
growth, socio-economic changes and emergence of resistant
new strains of Mycobacterium Tuberculosis (such as W and
Beijing) lead to re-emerging of TB. In 1993, due to the steady
increase in TB cases WHO declared a state of global emer-
gency for TB and called it as a global enemy in addition to
HIV and malaria [2].
The main goal of TB control programs is to arrest the
transmission within the community. An effective TB control
program requires early diagnosis and immediate initiation of
treatment. Delay in diagnosis in individuals and community
plays a crucial role in terms of disease prognosis and disease
transmission respectively [3].
Delay in the diagnosis and treatment of pulmonary tuber-
culosis results in increasing severity, mortality, and transmis-
sion of TB. Most transmissions occurs when the appearance
of cough in initiation of treatment. A published study reported
that patients become more contagious as the delay progresses.
In other words, the longest delays are associated with the high-
est bacillary numbers in sputum smears. On the other hand,
patients with delay in TB diagnosis are more likely to develop
pneumonia, other respiratory infections, and mortality in
emergency departments [4].
A systematic review on delay in TB diagnosis is shown
regardless of low or high endemic settings, a range of 60–
90 days for total delay in TB diagnosis [5]. Eastern Mediter-
ranean region of WHO (EMRO) also reported that the highest
time between onset of symptoms and disease diagnosis in Iran
was 127 days in 2006 [6]. Moreover, one other study argued
that the main cause of delay in TB patients in Iran is health-
care system oriented. In other words, the main delay was the
time taken by physicians to diagnose symptomatic patients
[7]. It suggested that the reasons for delay in diagnosis embed-
ded in cultural or educational deficiencies. However, post-
poned treatment initiation is rooted in the ability of the
national program of TB control in establishment of technical
and therapeutic facilities and providing the efficient control
system in a given country [7].
Delay in the diagnosis and treatment of TB patients will
result in spreading of infection in the community, increase in
severity of the disease and also a higher risk of mortality.
Therefore understanding the factors causing delay between
TB symptoms and therapy initiation is crucial to combatting
against the increasing TB epidemic, and to help healthcare sys-
tem in designing and implementing TB control programs.
Thus, aim of the present study is to determine the prognostic
factors that delay TB diagnosis.
Material and methods
This retrospective cohort study was conducted involving
1056 TB patients in Hamadan province, western Iran, from
2006 to 2014. The cohort involved all registered TB patients
with smear-positive, smear-negative or extra pulmonary. TB
cases were defined according to WHO and Iran’s national
TB guidelines [8]. To reach a homogenous sample and
generalize results to Iranian population, records of Afghanimmigrants, patients with probable diagnosis of TB and non-
native born citizens were excluded.
Data were extracted from the National TB Program (NTP)
as follow: background characteristics (gender, age, time of
diagnosis, source of reporting, place of residence (urban and
rural), and type of TB. Survival time was defined by symptom
onset until diagnosis. Delay time was categorized into less than
30 days, 31–90 days, and more than 90 days (which was
hypothesized as problem oriented delay).
The Log-rank test was used for comparison of survival
curves. The Kaplan–Meier curves were tested under the null
hypothesis that there is no significant difference between med-
ian of delay times. Null hypothesis is tested by Log-rank test.
The Cox regression model was used to evaluation simultane-
ous effects of prognostic variables on survival outcome. Pro-
portionality of hazards was tested using the Schoenfield test
and graphical schemes. P-value 60.05 was considered a signif-
icant level for all mentioned statistical tests. All analyses were
conducted in Stata software version 11 ((StataCorp, College
Station, TX, USA).
Results
Of the 1056 cases, N (%) of male and urban residence were 519
(49) and 649 (61) respectively. Table 1 shows the baseline char-
acteristics of the patients. The results showed that male
patients, relapse cases, and pulmonary positive patients com-
pared to the references had a significantly higher percent of
delay in diagnosis more than 90 days; but a significant differ-
ence was found between median delays for disease type
(Table 2).
The results of Cox’s proportional hazards model are
demonstrated in Table 3. The adjusted hazard ratios (HRs)
were statistically significant for treatment group, disease type,
and year of diagnosis. Hazard Ratio HR (95% CI) of patients
with pulmonary positive TB and extra pulmonary TB com-
pared to negative pulmonary TB patients was 0.8 (0.68, 0.94)
and 0.84 (0.73, 0.98) respectively. This figure for relapsed cases
compared to new cases was 0.67 (0.53, 0.85).
Fig. 1 shows Kaplan–Meier curves for survival adjusted for
gender, residency, disease type, and treatment group. Based on
Fig. 1, there are satisfactory conditions to use the Cox Propor-
tional models.
Discussion
Delay in TB case detection may worsen the disease and also
increase TB transmission in the society. The results of this
study showed that the median delay time in TB is higher in
females, and negative smear cases, also relapse cases and pul-
monary smear positive and extra pulmonary patients have
lower hazard for delayed diagnosis compared to other groups.
Results of other studies have shown that females [8–10], and
negative sputum smear cases [11,12] have experienced
increased diagnostic delay compared to males and other types
of TB. Specifically, the given negative smear results might lead
to a spurious confidence regarding not seeking further medical
attention [13].
Consistent with the report from Ghana [14], further median
delay in TB diagnosis in women in our study might be related
to the seeking medical center differences between men and
Table 1 Main characteristics of TB patients in Hamadan province, 2006–2014.
Variable No. (%) Timely presentation
(630 days), n= 153
Moderate delay
(31–90 days), n= 258
Problem oriented delay
(>90 days), n= 545
P value
Gender
Male 519(49) 90(17.34) 173(33.33) 256(49.33) 0.032
Female 537(51) 63(11.73) 185(34.45) 289(53.82)
Residency
Urban 649(61) 92(14.2) 211(32.5) 346(53.3) 0.36
Rural 407 61(15) 147(36.1) 199(48.9)
Age groups (Year)
<5 13 (1.5) 3(23.1) 4(30.77) 6(46.15) 0.38
5–14.9 16(1.5) 4(25) 4(25) 8(50)
15–29.9 164(15) 24(14.63) 65(39.63) 75(45.73)
30–44.9 201(19) 27(13.43) 75(37.31) 99(49.25)
45–59.9 187(18) 30(16) 66(35.3) 91(48.66)
60 475(45) 65(13.68) 144(30.32) 266(56)
Treatment group
New case 983 139(14.14) 345(35.1) 499(50.76) 0.01
Relapse case 73 14(19.2) 13(17.8) 46(63)
Disease type
Pulmonary (+) 510 85(16.67) 181(35.5) 244(47.8) 0.044
Pulmonary () 207 22(10.6) 61(29.5) 124(59.9)
Extra pulmonary 339 46(13.57) 116(34.22) 177(52.21)
Year of diagnosis
2006–2009 561 62(11.05) 183(32.62) 316(56.33) <0.001
2010–2014 495 91(18.38) 175(35.35) 229(46.26)
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Figure 1 Kaplan–Meier survival curves adjusted for: (A) gender; (B) residency; (C) TB type; (D) treatment group.
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Table 2 Comparison of median delay time in TB patients.
Variable Median delay
± 95% CI (day)
P value
(Log-rank)
Gender Male 90(80–96.3) 0.17
Female 96(89–109)
Residency Urban 96(89–105.9) 0.76
Rural 89(62.9–95)
Disease type Pulmonary (+) 86(75–93.6) 0.01
Pulmonary () 105(94.9–136)
Extra pulmonary 93(80.9–110.1)
814 S. Khazaei et al.women. Women in rural areas are dependent on their hus-
bands to take them to health services. In general, women expe-
rienced greater barriers such as financial, physical and stigma
than men [15].
We have found also that urban residents had a non-
significant higher median delayed time; this finding could be
challenged by the previous studies that showed due to poorer
access to medical facilities and socio-economic disadvantages,
rural residents have experienced a higher delayed diagnosis
[9,16–18]. This could be due to the establishment of health
houses in rural areas in Iran. In contrast to our results, in
one study in Bangladesh, delay in diagnosis in rural areas
was higher and it was due to the low level of knowledge and
awareness of the disease and income in rural areas [19].
Our finding showed pulmonary smear positive and extra
pulmonary cases have 20%, and 16% lower hazard for delayed
diagnosis compared to pulmonary negative cases. This finding
is in conflict with prior reports showing that extra pulmonary
cases have a higher chance of delayed diagnosis [20–23]. One
reason for this inconsistency could be due to long process
for detecting of smear negative pulmonary TB patients such
as sputum culture.Table 3 Hazard ratio and 95% confidence intervals of survival adj
Variables Unadjusted
Hazard ratio (95% CI)
Gender
Male Reference
Female 0.92(0.81, 1.04)
Residency
Urban Reference
Rural 0.98(0.87, 1.1)
Treatment group
New case Reference
Relapse case 0.69(0.54, 087)
Disease type
Pulmonary () Reference
Pulmonary (+) 0.8(0.68, 0.94)
Extra pulmonary 0.85(0.74, 0.98)
Year of diagnosis
2006–2009 Reference
2010–2014 1.22(1.08, 1.38)
* Adjusted for age, gender, residency.One of the important causes of delayed diagnosis of a TB
patient is attributed to the beliefs and attitudes that exist in
the community. It has been shown that lack of knowledge
about the TB, internalized stigma, shame of being a TB
patient, self-treatment, and seeking unqualified or traditional
practitioners plays a significant role as a barrier to timely
and proper diagnosis of TB [1,24–27].
We have also found that patients diagnosed in 2006–2014
had a higher risk for delayed treatment compared to the previ-
ous time period. This is questionable regarding to the anticipa-
tion of improvement in diagnostic tools in health care settings.
One explanation for observed paradox might be as a result of
the fact that most patients suffering from TB belonged to
deprived socio-economic classes where the ability of healthcare
settings to properly diagnose is not comparable with those in
larger cities in Iran.
Our study has some limitations. We used a registry based
data for analysis. Actually, we could not directly investigate
the effect of some variables such as household income, educa-
tion, and socio-economic status of patients on delayed treat-
ment; moreover the distinction between patient delay and
health care system was impossible. Delay time was based on
self-reporting of patients, therefore is prone to information
bias.
Conclusion
We found that females, urban residents, new cases and cases
with negative smear results, and the second half of the study
period had a higher risk for delayed TB diagnosis. Further
evaluation of these subgroups along with educational and
screening programs focusing on them would be beneficial for
the patients and the population as a whole. Improving health
staff education regarding TB symptoms and also implementing
active case finding in the populations may reduce delays.usted for covariates.
Adjusted*
P value Hazard ratio (95% CI) P value
0.17 Reference 0.16
0.91(0.8, 1.03)
0.77 Reference 0.74
0.98(0.86, 1.1)
0.002 Reference 0.001
0.67(0.53, 0.85)
Reference
0.009 0.8(0.68, 0.94) 0.009
0.028 0.84(0.73, 0.98) 0.024
0.001 Reference 0.001
1.23(1.09, 1.38)
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